Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3056 USD | -0.47% | -2.98% | -49.49% |
04-01 | China Pharma Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
02-23 | China Pharma to Conduct 1-For-5 Reverse Stock Split; Shares Fall After-Hours | MT |
Sales 2022 | 8.1M 11.16M | Sales 2023 | 7.01M 9.65M | Capitalization | 3.99M 5.49M |
---|---|---|---|---|---|
Net income 2022 | -3M -4.13M | Net income 2023 | -3M -4.13M | EV / Sales 2022 | 1.44 x |
Net Debt 2022 | 6.73M 9.26M | Net Debt 2023 | 3.21M 4.42M | EV / Sales 2023 | 1.03 x |
P/E ratio 2022 |
-1.27
x | P/E ratio 2023 |
-0.66
x | Employees | 231 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 33.37% |
1 day | -0.47% | ||
1 week | -2.98% | ||
Current month | -0.49% | ||
1 month | -17.98% | ||
3 months | -29.34% | ||
6 months | -34.91% | ||
Current year | -49.49% |
Managers | Title | Age | Since |
---|---|---|---|
Zhi Lin Li
CEO | Chief Executive Officer | 71 | 99-01-27 |
Members of the board | Title | Age | Since |
---|---|---|---|
Zhi Lin Li
CEO | Chief Executive Officer | 71 | 99-01-27 |
Gene Bennett
BRD | Director/Board Member | 76 | 08-01-31 |
Heung Mei Tsui
BRD | Director/Board Member | 67 | 09-04-27 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-01 | 0.3056 | -0.47% | 45 927 |
24-04-30 | 0.307 | +0.34% | 90,618 |
24-04-29 | 0.306 | +1.22% | 289,513 |
24-04-26 | 0.3023 | -7.27% | 233,061 |
24-04-25 | 0.326 | +3.49% | 191,630 |
Delayed Quote Nyse, May 01, 2024 at 10:46 am
More quotes1st Jan change | Capi. | |
---|---|---|
-49.49% | 4.55M | |
+32.99% | 704B | |
+28.25% | 577B | |
-4.36% | 348B | |
+18.51% | 327B | |
+4.88% | 288B | |
+14.65% | 234B | |
+4.93% | 198B | |
-9.78% | 194B | |
-4.50% | 147B |
- Stock Market
- Equities
- CPHI Stock